FFH
FSTX

Fairfax Financial Holdings’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Fairfax Financial Holdings’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-49,399
Closed -$312K – 73
2022
Q4 		$312K Buy
49,399
+25,000
+102% +$138K 0.01% 68
2022
Q3 		$125K Buy
+24,399
New +$153K ﹤0.01% 72

Fairfax Financial Holdings's FSTX Position: Q1 2023 in Review

Fairfax Financial Holdings sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 49,399 shares — an estimated $312K sold.

Fairfax Financial Holdings first reported a position in FSTX in Q3 2022 and held it in 2 quarters. The position peaked at $312K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Fairfax Financial Holdings reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Fairfax Financial Holdings sold 49,399 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $312K.
  • Fairfax Financial Holdings first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Fairfax Financial Holdings's F-star Therapeutics, Inc. Common Stock position peaked at $312K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Fairfax Financial Holdings's 13F filing for Q1 2023, filed 15 May 2023.